Cargando…
A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA
BACKGROUND: Methylated SDC2 has been proved as a diagnostic marker for human colorectal cancer (CRC), noninvasive stool DNA-based methylation testing also emerges as a novel approach for detecting CRC. The aim of this study was to evaluate the clinical performance of stool DNA-based SDC2 methylation...
Autores principales: | Ma, Liang, Qin, Geng, Gai, Fei, Jiang, Yongwei, Huang, Zhan, Yang, Hui, Yao, Shukun, Du, Shiyu, Cao, Yongtong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014784/ https://www.ncbi.nlm.nih.gov/pubmed/35436855 http://dx.doi.org/10.1186/s12876-022-02264-3 |
Ejemplares similares
-
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
por: Han, Yoon Dae, et al.
Publicado: (2019) -
Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021) -
Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
por: Oh, Tae Jeong, et al.
Publicado: (2017) -
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
por: Zhang, Weisong, et al.
Publicado: (2021) -
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Publicado: (2022)